Cargando…
Natural Compounds: Co-Delivery Strategies with Chemotherapeutic Agents or Nucleic Acids Using Lipid-Based Nanocarriers
Cancer is one of the leading causes of death, and latest predictions indicate that cancer- related deaths will increase over the next few decades. Despite significant advances in conventional therapies, treatments remain far from ideal due to limitations such as lack of selectivity, non-specific dis...
Autores principales: | Teixeira, Patrícia V., Fernandes, Eduarda, Soares, Telma B., Adega, Filomena, Lopes, Carla M., Lúcio, Marlene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141470/ https://www.ncbi.nlm.nih.gov/pubmed/37111802 http://dx.doi.org/10.3390/pharmaceutics15041317 |
Ejemplares similares
-
Covalent Organic Frameworks as Nanocarriers for Improved Delivery of Chemotherapeutic Agents
por: Liu, Weiming, et al.
Publicado: (2022) -
Spectroscopic Studies as a Toolbox for Biophysical and Chemical Characterization of Lipid-Based Nanotherapeutics
por: Fernandes, Eduarda, et al.
Publicado: (2018) -
Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
por: Kang, Lin, et al.
Publicado: (2015) -
pH-Responsive Hybrid Nanoassemblies for Cancer Treatment: Formulation Development, Optimization, and In Vitro Therapeutic Performance
por: Teixeira, Patrícia V., et al.
Publicado: (2023) -
Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery
por: Dey, Arindam K., et al.
Publicado: (2021)